| ID | Peptide Seq | Site Residue | Position in Peptide | Position in Protein |
|---|---|---|---|---|
| 10000323 | TETIRPASIFTKR | S | 506 | |
| 10008605 | TETIRPASIFTKR | S | 8 | 506 |
| ID | Method | Analytical Throughput | Ambiguity | Species | Sample Type | Condition | log2Ratio | P Value | Data Source PMID | Comments |
|---|---|---|---|---|---|---|---|---|---|---|
| 10000323 | MS | HTP | unambiguous | rat | cardiac mitochondria | TMG/control | -1.829982023 | 26446791 | Relative site occupancy ratios (ROR)' described in the original paper have been used as FC to calculate log2FC shown here. | |
| 10008605 | MS | HTP | unambiguous | rat | heart (mitochondria) | 26446791 |
| ID | Peptide Seq | Site Residue | Position in Peptide | Position in Protein | Method | Analytical Throughput | Ambiguity | Species | Sample Type | Data Source PMID | Comments |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10000323 | TETIRPASIFTKR | S | 506 | MS | HTP | unambiguous | rat | cardiac mitochondria | 26446791 | Relative site occupancy ratios (ROR)' described in the original paper have been used as FC to calculate log2FC shown here. | |
| 10008605 | TETIRPASIFTKR | S | 8 | 506 | MS | HTP | unambiguous | rat | heart (mitochondria) | 26446791 |